Conclusions. Although percutaneous balloon mitral commissurotomy appears to be effective at relieving the hemodynamic effects of rheumatic mitral stenosis, it does have risks. In properly selected patients, however, it appears to have low morbidity and 30-day mortality. Individual center experience with the procedure also appears to have great impact on complications. (Circulation 1992;85:2014-2024 
lthough the standard treatment for patients with severe symptomatic rheumatic mitral stenosis who do not have anatomy requiring valve replacement has been either open or closed surgical commissurotomy, the introduction of a percutaneous balloon technique, as first described by Inoue et all in 1984 , has led to enthusiasm about the use of this nonsurgical procedure. The use of percutaneous balloon mitral commissurotomy has been reported to have been successful in both the pediatric2 and the adult populations. [3] [4] [5] [6] [7] [8] The rates of complication and mortality in patients undergoing closed9-12 or open13-15 surgical mitral commissurotomy have been defined; these rates have not been well established, however, in patients undergoing percutaneous balloon mitral commissurotomy.
In response to the increasing use of this technique, the National Heart, Lung, and Blood Institute (NHLBI) established the Balloon Valvuloplasty Registry in November 1987 . The purpose of this registry was to characterize the patient population undergoing this procedure at a cross section of selected centers across North America. The coordinating center for the registry was the University of Washington in Seattle, and 23 additional sites were chosen to enter patients (see "Appendix"). One center in the registry did not perform balloon mitral commissurotomy. The efficacy and safety, technical aspects, clinical outcome, complications, and mortality of the procedure were to be defined. Enrollment in the registry began on November 1, 1987, and ended October 31, 1989 .
The purpose of this report is to provide an in-depth description of the technical aspects of the balloon commissurotomy procedure and to present and analyze data on procedural complications and mortality within the first 30 days.
Methods

Data Collection
Percutaneous balloon mitral commissurotomy was performed with individual institutional review board approval at all sites. All patients aged 18 or older undergoing percutaneous balloon mitral commissurotomy at each clinical site were approached before the procedure for inclusion in the registry. Informed consent was obtained from all patients, and each patient was prospectively entered into the registry at the time consent was obtained. In patients undergoing diagnostic catheterization, balloon commissurotomy was consid-ered to begin with the introduction of equipment specifically for the procedure. Selection criteria were not mandated by the registry and varied from center to center. Some patients entered would have been considered excellent candidates for surgical commissurotomy, and others would have been considered poor candidates or inoperable.
Baseline data including demographic, angiographic, hemodynamic, echocardiographic, and functional status were collected on all patients in the registry and are detailed elsewhere.'6 An echocardiographic scoring system, as previously reported,17 was used to assess valvular pathology. Data Balloon Commissurotomy Procedure Nine percent of the cases were not completed (see Table 1 ). All Serious complications, defined as cerebrovascular accident, embolic event, acute mitral incompetence, development of acute pulmonary edema, perforation of a cardiac chamber, tamponade, emergency cardiac surgery, myocardial infarction, development of cardiogenic shock, or death, occurred in 87 procedures, or 12%, and are depicted in Table 3 . Death in the laboratory occurred in eight patients (1 %) . It occurred with similar frequency during both years of enrollment.
However, the incidences of tamponade, perforation, the requirement for pericardiocentesis, transfusion, and death within 30 days were all significantly less frequent 9 7 NS in the second year of enrollment ( Table 4 ). The incidence of acute mitral regurgitation was higher in the second year than in the first year of enrollment. The requirement for mitral valve surgery within the first 30 days after the procedure was similar during both years. Cerebrovascular accident and embolic event each occurred in 2%. History of cerebrovascular disease did not influence the rate of cerebrovascular accident (3% with cerebrovascular disease versus 2% without, p=NS), but patients with a history of thromboembolic event had a higher cerebrovascular accident rate (6% versus 2%, p=0.003). Those with cerebrovascular accident tended to be older (62±+16 versus 54±+15 years, p=0.03). Evidence of a left atrial thrombus or possible thrombus by standard two-dimensional echocardiography was predictive of cerebrovascular accident (13% versus 2%,p=0.0004), as was an echo score greater than 10 (6% versus 2%,p=0.02). Transesophageal echo was not routinely used during the period of enrollment.
Patients who had thromboembolic events tended to be older (64+14 versus 54+15 years,p=0.007) and have a higher echo score (9.3+3 versus 7.9±2, p=0.04) . The thromboembolic event rates were higher in patients with grade four echo scores for calcification and leaflet thickening (11% versus 2%, p=0.0001 and 14% versus 2%, p=0.0001, respectively). They were also higher in patients with atrial fibrillation (3% versus 1%,p=0.05) and among patients with prior valve surgery (4% versus 2%, p=0.08). Gender and prior balloon commissurotomy were not associated with thromboembolic events. Eight had a history of previous thromboembolic event; one occurred within 6 months before the procedure and seven occurred more than 6 months before. The rate of thromboembolic events was higher among patients with possible thrombus by echocardiography (13% versus 2%, p=0.0002) and those with a prior event (7% versus 1%, p=0.0003).
Twenty-four patients developed acute mitral regurgitation. Fourteen had no mitral regurgitation before the procedure, eight had only mild regurgitation, and two had moderate regurgitation. Acute mitral regurgitation occurred with similar frequency among those with no or mild incompetence and those with moderate or severe incompetence before the procedure (3.3% versus 2.9%, p=NS). The total balloon diameter was not different in Table 6 gives details of the 12 procedurally related deaths occurring in the registry. The overall incidence of procedural death was 1.6%, with the most common complication that resulted in death being cardiac perforation and the development of cardiac tamponade and cardiogenic shock (0.9%). Of those patients not having cardiac perforation, one patient had a cerebrovascular accident resulting in death. A coronary embolus of calcific material to the left main coronary artery resulted in one death despite attempts at emergency angioplasty and intra-aortic balloon counterpulsation assist. A pulmonary embolus occurred in one patient after vascular repair of the venous access site, and one patient died in surgery after development of acute mitral incompetence after the procedure. Rupture of a pulmonary artery occurred in one patient. Table 7 shows complications that occurred in hospital and excludes complications that occurred in the laboratory. Two hundred ninety-four patients (40%) had at least one complication during their initial admission for balloon commissurotomy (Tables 2, 3 , and 7). The most common in-hospital complications included cardiac surgery in 0.7%, systemic thromboembolic event in 0.7%, transfusion in 0.5%, cerebrovascular accident in 0.4%, and in-hospital death in 1.6%.
Forty-one (6%) of the patients had mitral valve surgery during the initial hospitalization. Indications for surgery included inadequate mitral balloon commissurotomy in three patients, worsened mitral regurgitation in 10 patients, incomplete procedure in 24 patients, stabilization for planned surgery in two patients, and unknown or other indications in one each. Of these, 73% had replacement of the valve at the time of surgery.
Follow-up
Events after discharge. (See Table 8 .) During the first 5 weeks after discharge from the hospital, recurrent events were unusual. Syncope or near syncope, mitral valve surgery, and repeat hospitalization were most common. Twelve patients underwent mitral valve surgery after discharge from the initial hospitalization. Indications for surgery included inadequate initial balloon commissurotomy in seven patients, worsened mitral regurgitation in two patients, and incomplete procedure in three patients.
Thirty-day mortality. Within the first 30 days, there were 24 deaths, 18 cardiac and six noncardiac. Twenty of the 24 deaths occurred in hospital before discharge. Seventeen of the 24 deaths occurred during the first year of registry enrollment, and seven occurred during the second year (p=0.05). (>13) (p<0.05) . In addition, a mitral valve area of less than 0.7 cm2 before the procedure, a mean left atrial pressure > 12 mm Hg, or a mitral valve area of < 1.5 cm2 after the procedure also predicted higher early mortality. Higher echo score and lower valve area before the procedure were the strongest multivariate predictors of early mortality (p<0.001).
The effect of the case volume of individual centers on adverse events is depicted in Table 11 . Of interest is a trend toward fewer complications at sites with higher case volume. This is true not only for minor complications occurring in the laboratory but also for more serious complications including death, perforation, and the development of cardiac tamponade. In addition, there was also a decrease in in-hospital complication rates with increasing case experience. Importantly, events by 30 days, including death and the requirement for mitral valve surgery, were substantially decreased with increasing case volume. Clearly, the incidence of complications decreases with increasing experience.
Discussion
Since the procedure was first described by Inoue et al,1 a number of reports have appeared in the literature attesting to the ability of percutaneously placed balloons to yield favorable hemodynamic results in patients with severe rheumatic mitral-stenosis. [2] [3] [4] [5] [6] [7] [8] 16, [18] [19] [20] [21] We have presented data on the largest series to date of patients undergoing percutaneous mitral balloon commissurotomy.
Despite the favorable hemodynamic results reported, only limited data in relatively small numbers of patients exist that report the mortality and complications of the procedure. In Inoue's original report,' five of the six patients had successful balloon commissurotomy, and no complications or deaths were reported. Lock and colleagues2 described the use of the procedure in eight children and young adults and reported a single complication of cardiac perforation caused by a guide wire without the development of tamponade. Babic et a14 reported on three patients undergoing balloon mitral commissurotomy; none of these had complications. In a subsequent report,20 Babic's group reported the complications in 76 patients undergoing the procedure. Two patients (2.6%) developed significant mitral regurgitation, three (3.9%) had a cerebrovascular accident, and one (1.3%) died. Complications were felt to be more common in patients with calcified and immobile mitral valves. Al Zaibag et a17 and McKay et al8 reported on We have described the results of percutaneous balloon mitral commissurotomy in 738 patients undergoing the procedure at 23 institutions in North America. Serious complications occurred in 12%. Death in the cardiac catheterization laboratory occurred in 1%. Thirty-day mortality was 4%.
Although percutaneous balloon mitral commissurotomy appears effective at relieving the hemodynamic effects of rheumatic mitral stenosis, it does have important risks. Complications of the procedure do appear to be importantly affected by the experience of the individual center. Death during the procedure is reduced (2% versus 0.5%) in patients otherwise considered good candidates for surgical commissurotomy. Therefore, in properly selected patients treated in experienced centers, this procedure can be done with low risk and excellent short-term outcome.
Patients best suited for this procedure include those of younger age without evidence of left atrial thrombus NHLBI Balloon Valvuloplasty Registry Participants Balloon Mitral Commissurotomy 2023 or possible thrombus by standard two-dimensional echocardiography, those with a lower echo score, and those considered to have low surgical risk. Centers that have performed more than 25 procedures likewise seem best suited to offer patients lower morbidity and mortality. Additional long-term follow-up will be required to fully elucidate the outcome of patients undergoing percutaneous balloon mitral commissurotomy.
